David Erlinge
141 – 150 of 523
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial Infarction
- Contribution to journal › Article
-
Mark
Differences in biomarker concentrations and predictions of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarction
- Contribution to journal › Article
-
Mark
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population
- Contribution to journal › Article
-
Mark
Cost-effectiveness of adding a non-invasive acoustic rule-out test in the evaluation of patients with symptoms suggestive of coronary artery disease : Rationale and design of the prospective, randomised, controlled, parallel-group multicenter FILTER-SCAD trial
- Contribution to journal › Scientific review
-
Mark
MVnet : automated time-resolved tracking of the mitral valve plane in CMR long-axis cine images with residual neural networks: a multi-center, multi-vendor study
- Contribution to journal › Article
-
Mark
The association of mode of location activity and mobility with acute coronary syndrome : a nationwide ecological study
- Contribution to journal › Article
-
Mark
Characteristics and outcomes in patients with atrial fibrillation and acute coronary syndrome treated with ticagrelor and novel oral anticoagulants
- Contribution to journal › Article
- 2020
-
Mark
Qualitative assessments of myocardial ischemia by cardiac MRI and coronary stenosis by invasive coronary angiography in relation to quantitative perfusion by positron emission tomography in patients with known or suspected stable coronary artery disease
- Contribution to journal › Article
-
Mark
Antithrombotic therapy in atrial fibrillation : stop triple therapy and start optimizing dual therapy?
- Contribution to journal › Letter
-
Mark
Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction : A Prespecified Subgroup Analysis of the VALIDATE-SWEDEHEART Trial
- Contribution to journal › Article
